Queen’s Award Recognition for Breast Cancer Removal Company

Surgical guidance company Endomag has received the Queen’s Award for Enterprise in Innovation for 2018, for its efforts in developing novel surgical tools for more accurate removal of breast cancer.

The company has developed a minimally invasive surgical guidance system using magnetic sensing and nanotechnology, allowing surgeons to locate early-stage breast cancers with greater precision. The system helps to maximise the amount of healthy tissue left behind and determine whether the cancer has spread. These techniques can greatly improve the experience for patients, save vital hospital resources and have been shown to match current gold standards for accuracy in numerous clinical trials, said the company.

Launched in Europe in 2013, Endomag’s device has been used in over 30,000 breast cancer procedures, at 300 hospitals in 30 countries. More recently the Company has launched the device in the US and Canada where it has already been used in thousands of procedures across North America and is currently being evaluated by over a hundred hospitals. Major cancer centres including University of California, San Francisco and University Hospitals Seidman Cancer Center, Cleveland have already adopted the system into routine use.

Eric Mayes, CEO at Endomag said: “We’re so pleased to receive Royal recognition for what our team has been able to achieve. We pride ourselves on the relationships we’ve developed with clinicians across the world and actively use their expertise to help shape the products we develop.

It’s a particularly proud moment for me to know that UK businesses, like Endomag, are developing products that have real impact on people’s lives. It’s vitally important that we can demonstrate that the UK is able to lead on innovation and develop products and services that improve lives in all corners of the world.”